(15056629), L. M. G., (15056632), R. O., (15056635), A. S., (15056638), M. M. T., (15056641), M. S., (15056644), D. C., . . . (15051360), K. G. (2025). Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.
Citace podle Chicago (17th ed.)(15056629), Lindsay M. Gurska, et al. Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. 2025.
Citace podle MLA (9th ed.)(15056629), Lindsay M. Gurska, et al. Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. 2025.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..